Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 09/03/2008 Portrait of Dr. Anja Apel

    Successful attack on resistant tumour cells

    In laboratory experiments Dr. Anja Apel from the University Hospital in Heidelberg proved that cancer cells that are resistant to radiation therapy can be made to become susceptible to this kind of treatment again by blocking the cells own recycling system.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/successful-attack-on-resistant-tumour-cells
  • Article - 07/03/2008

    Hans-Ulrich Kauczor - expert in diagnostic radiology

    Since the 1st March 2008 the Department of Diagnostic Radiology at the University Hospital in Heidelberg has a new medical director Professor Dr. Hans-Ulrich Kauczor 45 succeeds Professor Dr. Günter Kauffmann.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/hans-ulrich-kauczor-expert-in-diagnostic-radiology
  • Article - 02/03/2008

    Miniature device offers great opportunities

    The Dietmar Hopp Foundation has donated one million euro for a new small-animal tomograph at the University Hospital in Heidelberg. The new system is suitable for small animals such as rats and mice and can be used to investigate diseases and therapies.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/miniature-device-offers-great-opportunities
  • Article - 28/02/2008

    Gilbert Gorr - a great fan of the moss Physcomitrella patens

    Dr. Gilbert Gorr has been fascinated by the moss Physcomitrella patens for many years in fact it occupies a great deal of his waking moments. The enthusiasm with which the CSO of greenovation Biotech GmbH talks about the key object of his work is both intoxicating and contagious. The latest discovery The moss produces a therapeutic antibody that is far more effective than its predecessors created in animal cell cultures.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/gilbert-gorr-a-great-fan-of-the-moss-physcomitrella-patens
  • Article - 16/02/2008

    Haemochromatosis is a disease of the liver

    Haemochromatosis is not as has been previously assumed a disease of the small intestine but a disease of the liver. Scientists from Heidelberg have shown in the animal model that the disease is caused by a mutated gene influencing hepcidin production.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/haemochromatosis-is-a-disease-of-the-liver
  • Article - 16/02/2008

    New test for the early diagnosis of cervical cancer

    mtm laboratories has launched the Cervatec assay for the early diagnosis of cervical cancer. The Cervatec assay will initially be commercialized as an adjunct to the Pap test for the screening of women aged 35 and younger.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/new-test-for-the-early-diagnosis-of-cervical-cancer
  • Article - 10/02/2008 DAccepted the invitation to come to Reutlingen and talk about biomarkers (from left to right) - Mike Spain, Hanno Langen, Thomas Caskey, Larry Gold, Oliver Poetz, Thomas Joos und Hans Berger (Photo: NMI)

    4th Biomarker Workshop at the NMI in Reutlingen: another success

    The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130 this years workshop exceeded all previous ones. Those who were keen to find out more about the latest trends and findings were presented with a successful mix of basic and applied research information.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/4th-biomarker-workshop-at-the-nmi-in-reutlingen-another-success
  • Article - 09/02/2008

    A better alternative from the perspective of embryo protection

    Karin Bundschuh of BIOPRO Baden-Württemberg asked Dr. Jens Clausen how these developments should be viewed from an ethical perspective. The bioethicist spent many years studying the status of embryos the ethics of cloning and stem cell research.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/a-better-alternative-from-the-perspective-of-embryo-protection
  • Article - 08/02/2008

    New specialist outpatient clinic offers help for people suffering from haemochromatosis

    A new specialist outpatient clinic at the University Hospital of Ulm is treating haemochromatosis sufferers and is investigating the causes of this disease. Haemochromatosis which as the effect of poisoning the body is one of the most frequent hereditary diseases.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/new-specialist-outpatient-clinic-offers-help-for-people-suffering-from-haemochromatosis
  • Article - 07/02/2008 The new life sciences research building on the Ulm University Campus with its transparent facade (Photo: University of Ulm)

    New life sciences centre in Ulm

    The new Life Science Centre will house eleven interfaculty research groups dealing with aspects of tissue regeneration. The state of Baden-Württemberg and the University both expressed their high expectations for the centre at the official opening.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/new-life-sciences-centre-in-ulm
  • Article - 05/02/2008 Portrait of Dr. Martin Schneider

    Protecting the liver from oxygen stress

    The Emmy Noether junior research group in the Department of Surgery at the University Hospital of Heidelberg is to be funded with 1.2 million over the next five years. The group will focus on how tissue damage in donor livers can be prevented. The group headed by Dr. Martin Schneider.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/protecting-the-liver-from-oxygen-stress
  • Article - 02/02/2008

    Mannheim: Excellence Centre of Dermatology

    The new University Clinic for Dermatology Venerology and Allergology building located on the Mannheim hospital campus has now been opened. The hospital directed by Prof. Dr. med. Sergij Goerdt treats approximately 2000 patients on an inpatient basis.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/mannheim-excellence-centre-of-dermatology
  • Article - 30/01/2008 The photo shows Prof. Valentin Wittmann sitting at a desk

    How cells communicate

    Prof. Valentin Wittmann professor in the Department of Chemistry at the University of Constance is investigating carbohydrates. At present his major area of interest is carbohydrate-RNA and carbohydrate-protein interactions where he is trying to understand the biological functions of complex sugar molecules glycans.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/how-cells-communicate
  • Article - 29/01/2008 Portrait of Dr. Claus-Wilhelm von der Lieth

    Breakthrough for glycomics

    New databases and bioinformatic tools provide the field of glycomics with a solid basis for dynamic development in molecular biology and medicine. Willi von der Lieth a researcher from Heidelberg was an important pioneer of glyco-bioinformatics. His sudden death is a great loss for this new scientific field.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/breakthrough-for-glycomics
  • Article - 28/01/2008

    Funding programme "Medical systems biology - MedSys"

    Proposals must be submitted prior to 7th May 2008.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/funding-programme-medical-systems-biology-medsys
  • Article - 25/01/2008

    Glycosylation pattern as potential target for intervention

    Tumours develop sophisticated strategies to escape the immune defence. One of these strategies is the modification of the cells sugar coat. Specific immune cell receptors bind to these sugars thereby preventing the tumour cell from being discovered by the immune system. Medics from the University of Tübingen are investigating the mechanisms involved and are looking for therapeutic targets.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/glycosylation-pattern-as-potential-target-for-intervention
  • Article - 21/01/2008

    Research alliance between French and German researchers

    Scientists from Ulm and Paris have joined forces to develop new medications against malignant brain tumours. The two-year research project will focus on developing betulinic acid which is found in abundance in birch bark into a cancer drug.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/research-alliance-between-french-and-german-researchers
  • Article - 19/01/2008

    Aiming for a National Centre for Dementia Research

    The Rhine-Neckar metropolitan region is hoping to become a National Centre for Dementia Research. Professor Beyreuther director of the NAR at the University of Heidelberg is coordinating the application.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/aiming-for-a-national-centre-for-dementia-research
  • Press release - 14/01/2008

    Prostate cancer: Improving the success of treatment

    Prostate cancer is the most frequent malignant tumour in men. Researchers from Freiburg and Bonn have succeeded in developing the basics for new therapies in particular for the treatment of advanced prostate cancer.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/prostate-cancer-improving-the-success-of-treatment
  • Article - 12/01/2008

    Peptide chips for improved cancer diagnostics

    Scientists at the German Cancer Research Centre DKFZ have now succeeded in generating peptides on a microchip - faster and thus cheaper than with previous methods.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/peptide-chips-for-improved-cancer-diagnostics
  • Press release - 07/01/2008

    TachoSil® to be marketed in the Unites States by Baxter

    Nycomed grants Baxter International Inc. NYSE BAX exclusive rights to market and distribute Nycomeds TachoSil patch in the United States. The agreement is part of Nycomeds strategy to seek marketing and commercialisation partnerships for the US market instead of operating its own sales force.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/tachosil-to-be-marketed-in-the-unites-states-by-baxter
  • Article - 05/01/2008

    MicroRNA switches off tumour protection

    The microRNA miR-21 suppresses the production of tumour suppressor Pdcd4 which protects cells from developing cancer. Researchers at the DKFZ have now found out that colorectal cancer cells in particular lack Pdcd4 while these cells have an oversupply of miR-21.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/microrna-switches-off-tumour-protection
  • Press release - 05/01/2008

    Nycomed files marketing authorisation application for fentanyl spray

    Nycomed filed a marketing authorisation application with the European Medicines Agency for an intranasal fentanyl spray in Europe. If approved the centralised filing could allow Nycomed to be the first to enter the market in 29 European countries with the fentanyl spray.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-files-marketing-authorisation-application-for-fentanyl-spray
  • Press release - 07/12/2007

    DKFZ and ZMBH form research alliance

    The German Cancer Research Centre and the Centre for Molecular Biology Heidelberg have created a new type of cooperation between the university and the Helmholtz Society. They hope that this will help increase their attractiveness to high-calibre scientists.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-and-zmbh-form-research-alliance

Page 29 / 29

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • sb_theme_biopro.domain.mdr-ivdr
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search